FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/101059 [Registered on: 14/01/2026] Trial Registered Prospectively
Last Modified On:
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Efficacy of Guggulu Marichadi taila (Topical) along with Rasamanikya (Oral) versus Rasamanikya (Oral) alone in the management of Psoriasis w.s.r. to Eka Kushta 
Scientific Title of Study   A Randomized Controlled Clinical Study to evaluate the efficacy of Guggulu Marichadi taila (Topical) along with Rasamanikya (Oral) versus Rasamanikya (Oral) alone in the management of Psoriasis w.s.r. to Eka Kushta 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Ashish Jamuna Parsad Dubey  
Designation  PG Scholar 
Affiliation  Padmashree Dr DY Patil Deemed to be University , School of Ayurveda. 
Address  DY Patil Ayurvedic Hospital, 1st floor, Kayachikitsa Department OPD No.1, sector 7, Nerul east , Navi Mumbai.

Thane
MAHARASHTRA
400706
India 
Phone  8692947685  
Fax    
Email  ash.dub.bams24@dypatil.edu  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ashish H Mhatre 
Designation  Associate Professor 
Affiliation  Padmashree Dr DY Patil Deemed to be University , School of Ayurveda. 
Address  DY Patil Ayurvedic Hospital, 1st floor, Kayachikitsa Department OPD No.1, sector 7, Nerul east , Navi Mumbai.

Thane
MAHARASHTRA
400706
India 
Phone  9819639895  
Fax    
Email  ashish.mhatre@dypatil.edu  
 
Details of Contact Person
Public Query
 
Name  Dr Ashish H Mhatre 
Designation  Associate Professor 
Affiliation  Padmashree Dr DY Patil Deemed to be University , School of Ayurveda. 
Address  DY Patil Ayurvedic Hospital, 1st floor, Kayachikitsa Department OPD No.1, sector 7, Nerul east , Navi Mumbai.

Thane
MAHARASHTRA
400706
India 
Phone  9819639895  
Fax    
Email  ashish.mhatre@dypatil.edu  
 
Source of Monetary or Material Support  
Padmashree Dr DY Patil Deemed to be University , School of Ayurveda, sector 7 , Nerul east , Navi Mumbai ,400706 
 
Primary Sponsor  
Name  Dr. Ashish Dubey 
Address  Padmashree Dr DY Patil Deemed to be University , School of Ayurveda, sector 7 , Nerul east , Navi Mumbai ,400706  
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ashish Dubey  DY Patil Ayurvedic Hospital  Padmashree Dr DY Patil Deemed to be University , School of Ayurveda ,1st floor , Kayachikitsa Department OPD No. 1, Nerul east , Navi Mumbai
Thane
MAHARASHTRA 
8692947685

ash.dub.bams24@dypatil.edu 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Padmashree Dr DY Patil Deemed to be University , School of Ayurveda   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L409||Psoriasis, unspecified. Ayurveda Condition: EKAKUSHTHAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Guggulu Marichadi Taila, Reference: Ashtanga Hridayam chikitsa sthan, Route: Topical, Dosage Form: Taila, Dose: 15(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 60 Days, anupAna/sahapAna: No, Additional Information: -
(2) Medicine Name: Rasamanikya, Reference: Sidhabhaishajya manimala, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 60(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 60 Days, anupAna/sahapAna: Yes(details: ghee/honey), Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: Rasamanikya, Reference: Sidhabhaishajya manimala, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 60(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 60 Days, anupAna/sahapAna: Yes(details: -ghee/honey), Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Subjects with classical lakshana of eka
kushta(Psoriasis) and clinical features of
Psoriasis such as absence of sweating, extensive
localization, resembling the scales of fish.
2. Subjects of either sex between the age group of
18 and 60 years.
3. Subjects with duration of upto 5 years will be
selected.
4. Subjects with positive Auspitz sign. 
 
ExclusionCriteria 
Details  1. Subjects with uncontrolled metabolic disorders
like hypothyroidism, hyperthyroidism , DM .
2. Subjects with other systemic disorders like
Epilepsy , Kochs , HIV , etc.
3. Eka kushta ( Psoriasis ) with extracutaneous
manifestations. 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To evaluate the efficacy of Guggulu Marichadi Taila along with Rasamanikya in the management of Psoriasis w.s.r. to Eka Kushta  2 months 
 
Secondary Outcome  
Outcome  TimePoints 
To compare the the efficacy of Guggulu Marichadi Taila along with Rasamanikya and Rasamanikya alone in the management of Psoriasis w.s.r. to Eka Kushta  2 months 
To determine the combined efficacy of Rasamanikya and Guggulu Marichadi Taila in comparison to control.  2 months 
To observe and document any adverse effect or complications arising from the intervention during the study period.  2 months 
 
Target Sample Size   Total Sample Size="120"
Sample Size from India="120" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   30/01/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   A Randomized Controlled Clinical Study to evaluate the efficacy of Guggulu Marichadi taila (Topical) along with Rasamanikya (Oral) versus Rasamanikya (Oral) alone in the management of Psoriasis w.s.r. to Eka Kushta
The study aims to evaluate the efficacy of Guggulu Marichadi Taila in the management of Eka kushth 
A total of 120 patients will be randomly assigned into two groups , the patients will be selected based on the subjective ( rukshata , size of psoriatic patch , arunatva, kandu) and objective criteria (Auspitz sign , Candle grease sign ) seen in Psoriasis .
The medicine will be given for a total of 60 days and assessment will be done on the 0, 15th, 30 th and 60 the day .
 
Close